What Does It Cost to Create a Cancer Drug? Less Than You’d Think by GINA KOLATA


A new study suggests that biotech companies are spending far less than believed on research and development for approved drugs, despite rising prices.

Published: September 11, 2017 at 02:00AM

from NYT Health https://ift.tt/2vPB8zT